Biotech Breakthroughs

Results

85

9 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

85 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$507.56	-0.5%	37.2%	US$11.7b	US$678.06	9.1	63.7%	n/a	Pharmaceuticals & Biotech
	688192	CN¥60.91	8.8%	-28.5%	CN¥28.3b	CN¥83.00	31.7	104.5%	n/a	Pharmaceuticals & Biotech
	2480	HK$13.10	-3.7%	-44.3%	HK$2.6b	HK$31.00	3.4	77.1%	n/a	Pharmaceuticals & Biotech
	2171	HK$15.01	-2.1%	-33.9%	HK$8.9b	HK$21.19	61.0	80.6%	n/a	Pharmaceuticals & Biotech
	6990	HK$520.50	-3.5%	19.9%	HK$124.4b	HK$570.05	51.9	45.1%	n/a	Pharmaceuticals & Biotech
	2591	HK$6.61	-13.0%	-88.5%	HK$3.0b	HK$31.44	19.7	95.4%	n/a	Pharmaceuticals & Biotech
	A042520	₩21,050.00	-2.8%	145.1%	₩300.2b	n/a	2.4	67.0%	0%	Pharmaceuticals & Biotech
	INSM	US$123.74	-5.6%	-3.2%	US$27.0b	US$200.05	23.8	66.9%	n/a	Pharmaceuticals & Biotech
	PRAX	US$366.81	1.7%	679.1%	US$10.2b	US$623.68	7.6	71.6%	n/a	Pharmaceuticals & Biotech
	ARDX	US$4.06	1.5%	-32.0%	US$1.0b	US$13.00	2.2	60.7%	n/a	Pharmaceuticals & Biotech
	ANAB	US$58.47	3.3%	190.3%	US$1.7b	US$87.09	7.4	48.1%	38.5%	Pharmaceuticals & Biotech
	MRKR	US$1.14	1.8%	-9.5%	US$19.0m	US$7.87	7.1	72.5%	n/a	Pharmaceuticals & Biotech
	9926	HK$96.00	-4.0%	-42.0%	HK$88.4b	HK$167.82	24.9	46.0%	n/a	Pharmaceuticals & Biotech
	ZYME	US$25.12	6.7%	74.9%	US$1.8b	US$40.33	48.0	39.6%	n/a	Pharmaceuticals & Biotech
	IONS	US$57.24	1.2%	30.7%	US$9.5b	US$89.33	10.9	68.0%	n/a	Pharmaceuticals & Biotech
	BIOPOR	DKK 1.20	3.0%	-8.2%	DKK 591.7m	DKK 1.75	14.7	78.5%	n/a	Pharmaceuticals & Biotech
	MSB	AU$2.21	-0.9%	-12.0%	AU$2.9b	AU$3.93	31.1	51.0%	n/a	Pharmaceuticals & Biotech
	2487	HK$2.23	-11.9%	-76.1%	HK$810.3m	HK$11.28	2.1	99.3%	n/a	Pharmaceuticals & Biotech
	ABEO New	US$5.99	-17.3%	-16.1%	US$342.2m	US$18.86	13.4	70.5%	n/a	Pharmaceuticals & Biotech
	DBV	€2.37	1.7%	37.7%	€700.1m	€3.64	160.8	68.9%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.73	0.2%	-37.2%	US$163.3m	US$3.20	122.3	67.8%	n/a	Pharmaceuticals & Biotech
	RVMD	US$203.71	-0.7%	460.9%	US$43.7b	US$221.90	16.8	60.0%	n/a	Pharmaceuticals & Biotech
	CLRB New	US$2.60	1.2%	-40.1%	US$20.8m	US$11.50	0.7	56.0%	n/a	Pharmaceuticals & Biotech
	CAPR	US$6.65	62.6%	-16.5%	US$386.6m	US$10.50	1.6	63.0%	n/a	Pharmaceuticals & Biotech

Page 1 of 3